PGT Genetic Testing in Korattur, Chennai

Preimplantation Genetic Testing is not a single test but a family of procedures designed to evaluate the genetic health of an embryo before it is transferred to the uterus. PGT-A (Aneuploidy screening) checks whether an embryo has the correct number of chromosomes — 46 in total — and is the most widely recommended type for couples facing recurrent miscarriage, advanced maternal age, or repeated IVF failure. PGT-M (Monogenic disorder testing) is used when one or both partners carry a known genetic mutation such as thalassaemia, sickle cell anaemia, or cystic fibrosis, conditions that are not uncommon in Tamil Nadu's population.

For Korattur families — many of whom are government employees or first-generation urban professionals balancing careful financial planning with genuine medical need — the decision to pursue PGT is often driven by a painful history of pregnancy loss or a family-level awareness of hereditary conditions. The good news is that genetic testing does not necessarily require a different IVF cycle; it is integrated into the existing embryo culture process. HomeIVF's care coordinators based in Chennai help families in Korattur understand exactly which type of PGT applies to their situation, interpreting their medical history in plain language before any procedure begins.

Understanding the PGT journey from beginning to end helps families approach it with confidence rather than anxiety. The process begins with a thorough fertility assessment — including blood hormone panels, semen analysis, and a uterine evaluation — which HomeIVF coordinators arrange as home visits or at partner diagnostic centres near Korattur.

Once the decision to proceed with IVF plus PGT is made, the woman begins ovarian stimulation through injectable medications administered over 10–14 days, with regular ultrasound monitoring. At the time of egg retrieval, the male partner provides a semen sample for fertilisation in the laboratory. The resulting embryos are cultured for five to six days until they reach the blastocyst stage.

At this point, an embryologist performs a trophectoderm biopsy — removing a small cluster of cells from the outer layer of the blastocyst, which will eventually become the placenta. These cells are sent to an accredited genetics laboratory where next-generation sequencing (NGS) or array comparative genomic hybridisation (aCGH) identifies chromosomal status or specific mutations. Results typically take one to three weeks for PGT-A and up to four weeks for PGT-M. Embryos found to be chromosomally normal or unaffected by the targeted mutation are then transferred in a subsequent frozen embryo transfer (FET) cycle. HomeIVF's Chennai-based team coordinates every handoff in this chain, ensuring Korattur patients never feel lost between steps.

Not every IVF patient requires genetic testing, and responsible clinical guidance is about matching the right investigation to the right patient. The HomeIVF Medical Board endorses PGT-A most strongly in four clinical scenarios: women aged 35 and above undergoing IVF, couples who have experienced two or more unexplained miscarriages, patients who have had two or more failed embryo transfers despite good-quality embryos, and couples where one partner has a known chromosomal structural rearrangement such as a translocation.

PGT-M is a more targeted test and is advised when genetic carrier screening or a family history identifies a specific inheritable condition. In Chennai and Tamil Nadu broadly, thalassaemia trait is a relatively common carrier condition, and couples who are both carriers face a one-in-four chance with each pregnancy of having an affected child. PGT-M can screen embryos and identify those unaffected, offering a pathway to a healthy pregnancy without the ethical complexity of prenatal diagnosis followed by termination.

It is worth noting that PGT does not guarantee a live birth — it improves the probability of a successful transfer by selecting the most viable embryo. It also does not screen for all possible genetic conditions, only those the test is specifically designed to detect. Transparent communication about these boundaries is a cornerstone of how HomeIVF engages with families in Korattur and across Chennai.

When families in Korattur compare fertility options, they typically weigh cost, convenience, and quality of medical access. Most conventional IVF clinics in Chennai require patients to travel to facilities in areas like Nungambakkam, T Nagar, or Adyar — which from Korattur can mean 45 minutes to over an hour each way in peak traffic, multiplied across a dozen or more monitoring appointments.

HomeIVF takes a fundamentally different approach. The HomeIVF package is built around bringing clinical coordination to you. This includes initial teleconsultation with a senior fertility specialist, home-based or nearby diagnostic sample collection for blood work and semen analysis, structured care navigation through the IVF and PGT cycle, medication guidance and injection training for the stimulation phase, and dedicated coordinator support from the HomeIVF Chennai team throughout the process.

The laboratory procedures — egg retrieval, embryo culture, biopsy, and transfer — take place at an accredited partner clinic, but the surrounding ecosystem of care is managed by HomeIVF so that Korattur residents spend the minimum necessary time in traffic and the maximum time resting and recovering at home. HomeIVF packages starting from ₹1.5 lakh make this integrated model accessible to middle-income families, with transparent scope of inclusion communicated at the very first consultation.

Korattur's residential character makes it a strong match for the HomeIVF model. Unlike commercial areas of Chennai, Korattur is primarily a neighbourhood where people live, rest, and plan for the future — families here value privacy, predictability, and minimising disruption to daily work and family routines.

The ICF quarters community in particular includes many dual-income households where both partners are in government service with fixed working hours, making frequent mid-day clinic visits logistically difficult. The HomeIVF model accommodates this by scheduling home visits for blood draws and consultations around the patient's timetable rather than the clinic's.

Privacy is another significant consideration. Fertility treatment remains a sensitive topic in many Indian families, and the ability to receive care at home — without running into acquaintances in a clinic waiting room — is something Korattur residents consistently cite as a relief. Senior fertility specialists and embryologists associated with the HomeIVF network are accessible through video consultation, removing the geographical disadvantage that once made advanced reproductive care feel reserved for those living closer to Chennai's medical hubs. The HomeIVF care model is reviewed and structured by the HomeIVF Medical Board to meet the same clinical standards as any premium fertility centre.

Korattur sits in a well-connected but often traffic-congested part of northwest Chennai. The neighbourhood borders Kolathur to the east, Ambattur to the west, and is connected to Anna Nagar West via Padi. Korattur Lake, one of the area's green landmarks, anchors the residential zones to the south, while the ICF township forms a distinct community within the locality.

For residents considering fertility treatment, the proximity to Anna Nagar West means that certain diagnostics and pharmacy needs can be met within a short distance. However, for actual IVF procedures, the accredited partner facilities linked to HomeIVF in Chennai are typically a 20–35 minute drive depending on traffic, manageable when visits are limited to only the essential procedure days.

HomeIVF's Chennai coordination team is familiar with the logistics of Korattur and can recommend the nearest sample collection points, suggest optimal timings for procedure-day travel to avoid peak congestion on Padi–Kolathur Road and the Chennai Bypass, and arrange ambulatory support where required. The goal is to make the clinical journey from Korattur as smooth as possible, without ever compromising on the quality of genetic testing or embryology services.

Financial planning is a core concern for the majority of Korattur families considering PGT and IVF. Government employees covered under the Central Government Health Scheme (CGHS) or Tamil Nadu Government Health Scheme should verify the current coverage for assisted reproduction — while most insurance policies in India still exclude IVF, there is growing movement toward partial coverage for diagnostics, and some employer group policies do include fertility benefits.

For families without insurance coverage, EMI financing is a practical pathway. HomeIVF works with financing partners to offer structured payment plans that allow the treatment cost to be distributed over manageable monthly instalments, reducing the immediate financial burden. Many Korattur families choose to plan one IVF cycle at a time, combining consultation and diagnostic phases in the first month before committing to stimulation and PGT, which helps in budgeting step by step.

The HomeIVF Medical Board advises all couples to have a frank financial and medical discussion before beginning — understanding not just the cost of one cycle but the realistic probability of needing a second, and how genetic testing in the first cycle may reduce the overall expenditure by improving the chance of success per transfer. A planned approach, tailored to Korattur household budgets, is always more sustainable than reactive spending under emotional pressure.

Beginning your fertility journey with HomeIVF from Korattur is designed to be simple, private, and free of unnecessary clinical intimidation. The first step is booking a free initial consultation through the HomeIVF website or helpline — this is a no-obligation conversation with a care coordinator who will understand your medical history, ask about prior investigations or treatments, and outline whether PGT or another fertility pathway is likely relevant for you.

Following the initial consultation, the HomeIVF team will recommend a baseline fertility workup — typically including an AMH blood test, Day 2 or Day 3 hormonal panel, transvaginal ultrasound for antral follicle count, and a semen analysis. These can be arranged at a nearby partner collection centre in or close to Korattur, or through a home sample collection visit.

A senior specialist from the HomeIVF network will then review all results in a detailed video consultation, explaining findings, outlining a personalised treatment plan, and answering questions about PGT in the context of your specific medical situation. All clinical recommendations are reviewed against protocols set by the HomeIVF Medical Board. Korattur residents have found this structured, step-by-step onboarding to be far less overwhelming than walking into a large fertility clinic — and it ensures that every rupee invested in treatment is backed by a well-informed clinical decision.